A Randomized, placebo-controlled trial of an amino acid preparation on timing and quality of sleep

American Journal of Therapeutics

Volumn 17, Issue 2, 2010, Pages 133-139

  Shell, William ^a   Bullias, Debbie ^b   Charuvastra, Elizabeth ^a   May, Lawrence A ^c   Silver, David S ^c  

^a Targeted Medical Pharma Inc   (United States)

^b Physician Therapeutics   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amino acid; Medical food; Sleep; Trial

Indexed keywords

AMINO ACID; GABADONE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AROUSAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; MALE; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; SNORING;

5-HYDROXYTRYPTOPHAN; AMINO ACIDS; CHOLINE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HUMANS; MALE; PILOT PROJECTS; QUESTIONNAIRES; SLEEP DISORDERS; TIME FACTORS;

EID: 77949970340     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31819e9eab     Document Type: Article

References (62)

1. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep. 2000;23(Suppl 1):S23-S30.
2. Bastien CH, LeBlanc M, Carrier J, et al. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep. 2003;26 3:313-317.
3. Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20:844-849.
4. Curzon G. The role and control of brain 5-hydroxytryptamine. Acta Neurol (Napoli). 1977;32:121-131.
5. George CF, Millar TW, Hanly PJ, et al. The effect of L-tryptophan on daytime sleep latency in normals: correlation with blood levels. Sleep. 1989;12:345-353.
6. Gottesmann C. GABA mechanisms and sleep. Neuroscience. 2002;111:231-239.
7. Bowers MB Jr, Hartmann EL, Freedman DX. Sleep deprivation and brain acetylcholine. Science. 1966;153: 1416-1417.
8. Maurizi CP. The therapeutic potential for tryptophan and melatonin: possible roles in depression, sleep, Alzheimer,s disease and abnormal aging. Med Hypotheses. 1990;31:233-242.
9. Nakajima T, Sasaki T, Nakagome K, et al. Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers. Life Sci. 2000;67:81-90.
10. Calvo JM, Datta S, Quattrochi J, et al. Cholinergic microstimulation of the peribrachial nucleus in the cat. II. Delayed and prolonged increases in REM sleep. Arch Ital Biol. 1992;130:285-301.
11. Jasper HH, Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science. 1971;172:601-602.
12. Koella WP. The organization and regulation of sleep. A review of the experimental evidence and a novel integrated model of the organizing and regulating apparatus. Experientia. 1984;40:309-338.
13. McGinty DJ, Drucker-Colin RR. Sleep mechanisms: biology and control of REM sleep. Int Rev Neurobiol. 1982;23:391-436.
14. Mendelson WB. Neurotransmitters and sleep. J Clin Psychiatry. 2001;62(Suppl 10):5-8.
15. Abetz L, Arbuckle R, Allen RP, et al. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population. Health Qual Life Outcomes. 2005;3:79.
16. Ancolio C, Tardieu S, Soubrouillard C, et al. A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice setting. Hum Psychopharmacol. 2004;19:129-134.
17. Haley RW, Vongpatanasin W, Wolfe GI, et al. Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am J Med. 2004;117:469-478.
18. Wurtman RJ, Lieberman HR. Melatonin secretion as a mediator of circadian variations in sleep and sleepiness. J Pineal Res. 1985;2:301-303.
19. Giedke H. On the role of serotonin in sleep regulation and depression. A commentary on-Neurobiological bases for the relation between sleep and depression- (J Adrien). Sleep Med Rev. 2003;7:101-102.
20. Grazia de SM, Imeri L, De MW, et al. Sleep regulation: interactions among cytokines and classical neurotransmitters. Adv Neuroimmunol. 1995;5:189-200.
21. Kayama Y, Koyama Y. Control of sleep and wakefulness by brainstem monoaminergic and cholinergic neurons. Acta Neurochir Suppl. 2003;87:3-6.
22. Mendelson WB. Neurotransmitters and sleep. J Clin Psychiatry. 2001;62(Suppl 10):5-8.
23. Morrison JL, Sood S, Liu H, et al. GABAA receptor antagonism at the hypoglossal motor nucleus increases genioglossus muscle activity in NREM but not REM sleep. J Physiol. 2003;548:569-583.
24. Penalva RG, Lancel M, Flachskamm C, et al. Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: a combined in vivo microdialysis/EEG study in rats. Eur J Neurosci. 2003;17:1896-1906.
25. Seigneur J, Kroeger D, Nita DA, et al. Cholinergic action on cortical glial cells in vivo. Cereb Cortex. 2006;16: 655-668.
26. Massironi G, Galluzzi S, Frisoni GB. Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies. Int Psychogeriatr. 2003;15:377-383.
27. Casey DE. The relationship of pharmacology to side effects. J Clin Psychiatry. 1997;58(Suppl 10):55-62.
28. Jobert M, Poiseau E, Jahnig P, et al. ECG activity in the sleep of insomniac patients under the influence of lormetazepam and zopiclone. Neuropsychobiology. 1995; 31:204-209.
29. Lemoine P, Allain H. Induction of sleep. Sleep. 1996; 19(Suppl):S1-S6.
30. Wagner J, Wagner ML, Hening WA. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother. 1998;32:680-691.
31. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med. 1983;6:101-197.
32. Blois R, Feinberg I, Gaillard JM, et al. Sleep in normal and pathological aging. Experientia. 1983;39:551-558.
33. Buguet A. Is sleeping sickness a circadian disorder? The serotonergic hypothesis. Chronobiol Int. 1999;16:477-489.
34. Curzon G. The role and control of brain 5-hydroxytryptamine. Acta Neurol (Napoli). 1977;32:121-231.
35. Drucker-Colin RR, Spanis CW. Is there a sleep transmitter? Prog Neurobiol. 1976;6:1-22.
36. Espana RA, Scammell TE. Sleep neurobiology for the clinician. Sleep. 2004;27:811-820.
37. Carchedi F, Di CM, Casacchia M, et al. Sleep: biochemical correlations and pharmacological considerations. Clin Ter. 1979;91:3-10.
38. Celesia GG, Jasper HH. Acetylcholine released from cerebral cortex in relation to state of activation. Neurology. 1966;16:1053-2063.
39. Crouzier D, Baubichon D, Bourbon F, et al. Acetylcholine release, EEG spectral analysis, sleep staging and body temperature studies: a multiparametric approach on freely moving rats. J Neurosci Methods. 2006;151:159-167.
40. Domino EF, Yamamoto K, Dren AT. Role of cholinergic mechanisms in states of wakefulness and sleep. Prog Brain Res. 1968;28:113-133.
41. Gaillard JM. Neurochemical regulation of the states of alertness. Ann Clin Res. 1985;17:175-184.
42. Gillin JC, Sitaram N, Mendelson WB. Acetylcholine, sleep, and depression. Hum Neurobiol. 1982;1:211-219.
43. Gillin JC, Mendelson WB, Sitaram N, et al. The neuropharmacology of sleep and wakefulness. Annu Rev Pharmacol Toxicol. 1978;18:563-579.
44. Graves L, Pack A, Abel T. Sleep and memory: a molecular perspective. Trends Neurosci. 2001;24:237-243.
45. Hilakivi I. Biogenic amines in the regulation of wakefulness and sleep. Med Biol. 1987;65:97-104.
46. Holman RB, Elliott GR, Barchas JD. Neuroregulators and sleep mechanisms. Annu Rev Med. 1975;26:499-520.
47. Jones BE. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci. 2005;26:578-586.
48. Jones BE. The organization of central cholinergic systems and their functional importance in sleep-waking states. Prog Brain Res. 1993;98:61-71.
49. Kalia M. Neurobiology of sleep. Metabolism. 2006; 55(Suppl 2):S2-S6.
50. Manfridi A, Brambilla D, Mancia M. Sleep is differently modulated by basal forebrain GABA(A) and GABA(B) receptors. Am J Physiol Regul Integr Comp Physiol. 2001; 281:R170-R175.
51. Monti JM, Jantos H, Monti D. Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABA(A) or adenosine A(1) receptor agonists. Behav Brain Res. 2001;123:23-35.
52. Swainston HT, Keating GM. Zolpidem: a review of its use in the management of insomnia. CNS Drugs. 2005;19: 65-89.
53. Babb SM, Ke Y, Lange N, et al. Oral choline increases choline metabolites in human brain. Psychiatry Res. 2004; 130:1-9.
54. Blusztajn JK, Wurtman RJ. Choline and cholinergic neurons. Science. 1983;221:614-620.
55. Erickson CK, Matchett JA. Correlation of brain amine changes with ethanol-induced sleep-time in mice. Adv Exp Med Biol. 1975;59:419-430.
56. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972;178:414-416.
57. Fernstrom JD, Wurtman RJ. Nutrition and the brain. Sci Am. 1974;230:84-91.
58. Dulloo AG, Seydoux J, Girardier L, et al. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000;24:252-258.
59. Luceri C, Caderni G, Sanna A, et al. Red wine and black tea polyphenols modulate the expression of cycloxygenase- 2, inducible nitric oxide synthase and glutathionerelated enzymes in azoxymethane-induced f344 rat colon tumors. J Nutr. 2002;132:1376-1379.
60. Richelle M, Tavazzi I, Offord E. Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem. 2001;49:3438-3442.
61. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130(Suppl):2073S- 2085S.
62. Shi J, Yu J, Pohorly JE, et al. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food. 2003;6: 291-299.